European Academy of Allergy and Clinical Immunology

EAACI Congress 2018
26 - 30 May 2018, Munich, Germany

UPCOMING EVENTS

EAACI Food Allergy Training Course

14 - 16 September 2017, Manchester, United Kingdom
Master Class on Occupational Allergy

29 - 30 September 2017, Madrid, Spain
PAAM 2017, Pediatric Allergy and Asthma Meeting

26 - 28 October 2017, London, United Kingdom
ISMA 2017, International Symposium on Molecular Allergology

09 - 11 November 2017, Luxembourg
Master Class on Biologicals

13 - 14 April 2018, Prague, The Czech Republic
DHM 2018, Drug Hypersensitivity Meeting

19 - 21 April 2018, Amsterdam, The Netherlands
Allergy School on Aerobiology and Pollution

15 - 17 March 2018, Dubrovnik, Croatia

FAAM 2018, Food Allergy and Anaphylaxis Meeting

18 - 20 October 2018, Copenhagen, Denmark

TOP STORIES

EAACI Master Class on Occupational Allergy

EAACI Master Class on Occupational Allergy will be hosted at the Hospital La Paz in Madrid, Spain, from 29-30 September 2017. The main goal is to review the importance and role of different known and potential biomarkers useful to define the pathophysiological and clinical profiles of patients affected by occupational lung disease, particularly occupational asthma. Check out the programme available online and make sure to submit your case reports.

Support “United Action for Allergy and Asthma” - A political Call to Action in Europe

EAACI has co-launched a campaign called "United Action for Allergy and Asthma" to raise awareness and improve health programmes surrounding allergy and asthma. The official launch took place at the European Parliament in Brussels on 25 April 2017. Until the end of September, all interested parties; individuals as well as organisations, can sign online and join this move to support stronger and improved allergy and asthma policies. For more information, please see our website.

Official Press release.

Pictures from EAACI Congress 2017 in Helsinki are now available online

EAACI Congress 2017 was a great success with more than 8000 attendees. We now have a selection of photos available on our website. Make sure you take a look!

EAACI Journals Allergy, PAI and CTA have new Impact Factors

The new impact factors for Allergy, PAI and CTA have set a new record for EAACI journals. Allergy - As one of the leading journals in the field of allergy and clinical immunology, Allergy has had a very successful year with a new impact factor of 7.361. PAI is the world's leading journal in pediatric allergy, and it has a new impact factor of 3.775. CTA is an open access online journal, and it has reached an impact factor for the first time, and it is an outstanding 3.239.

Thank you and congratulations to the editorial team, authors, reviewers and readers who greatly contributed to this success.

PAAM 2017 – Late Breaking Abstracts

PAAM is the largest International scientific meeting dedicated to allergic disease and asthma in childhood. As one of the flagship niche meetings held by EAACI, we have enjoyed the growing number of participants over the years, with over 1300 attendees at the last meeting. Have a look at the preliminary programme and join us for excellent learning and networking opportunities from 26 - 28 October in London. You now have the opportunity to submit late breaking abstracts for discussion by 21 August 2017.

NEWS & UPDATES

EAACI’s activities at the European Parliament in Strasbourg, November 22 and 23
Collecting MEPs signatures to the Written Declaration 115/2016 on CRDs together with other supporting organisations
Recruiting new MEPs to the European Parliament Interest Group on Allergy and Asthma (IGAA)
Representing the Academy at a spirometry test event where MEPs will have the opportunity to get their lungs tested

These activities will represent a good opportunity to continue raising the profile of EAACI at EU level and advocate the unmet needs of Allery and Asthma in Europe. To see the MEPs signatories of WD 115/2016 to date click here.
European Commission Directorate General for Research and Innovation opens public consultation on Horizon 2020
On the 20th of October, the European Commission DG Research & Innovation opened a public consultation on the EU funding programme for research and innovation Horizon 2020. The consultation is open until the 15th of January 2017 and provides an opportunity for all interested parties to give their views on the programme and suggestions for the future, in order to contribute to improving its overall functioning.
Read more
EAACI/AAAAI PRACTALL: The role of the microbiome
The PRACTALL program is a flagship common initiative of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. The goal of this joint project led by the Presidents of both the Academies is to share updated authoritative and evidence based recommendations for current hot topics relevant to our field.
Read more
4th Food Allergy and Anaphylaxis Meeting (FAAM) - World-Leading Experts in Food Allergy and Anaphylaxis gather in Rome to discuss new research findings and advancements in diagnosis and management
Read more
EAACI High-Level EU Stakeholders Lunch: ‘Working together to progress EU policies for the benefit of allergic patients in Europe’
The EAACI High-Level EU Stakeholders Lunch (June 13th 2016, Vienna) brought together representatives from the EU Institutions, patient advocates, allergy national societies, industry, and EAACI leadership to jointly reflect on collaborations to advance EU policies for the benefit of allergic patients.
Read more

Official Accommodation Partner for EAACI Congress 2017 in Helsinki
IMPORTANT ALERT: There are an increasing number of fraudulent websites and individuals that impersonate EAACI and our Congress but that are in no way associated with EAACI.
Read more
EAACI signed an open letter to Commissioner Timmermans, Andriukaitis and Katainen following the Conference ''Towards better prevention and management of chronic diseases'' of 21 April
EAACI as member of ECDA together with ten prominent health organisations sent an open letter to high level Commission officials in the follow up of the conference ''Towards better prevention and management of chronic diseases'' of 21 April. Click here to read the letter.
Preventing Chronic Diseases – opportunities for patients and citizens

EC Conference “Towards better prevention and management of chronic diseases”, Brussels 21 April 2016
EAACI is a member of the ECDA, a Coalition of 11 European health organisations representing millions of patients and 200,000+ health professionals. A call for a comprehensive EU framework on chronic diseases was launched at the meeting.
Read more
The Alliance for Biomedical Research in Europe adopts the CODE OF CONDUCT for Healthcare Professionals and Scientific Organizations Members
Read more
European Commission opens consultation on regulated professions in the EU
This consultation has been launched with the overall aim to improve national regulatory frameworks for regulated professions such as doctors, which significantly vary between Member States and require professionals to be granted authorizations to conduct their activity in addition to their qualifications. Have your saying on the National Action Plans. Deadline 19th of August 2016
Read more

Update from Stallergenes Greer
Product recalled analyses show product compliance with required specifications
More than 250,000 treatments delivered since the restart of manufacturing and distribution
Read more
International Research Scholars Program
The Howard Hughes Medical Institute (HHMI), the Bill & Melinda Gates Foundation, the Wellcome Trust, and the Calouste Gulbenkian Foundation announce the International Research Scholars Program which aims to support up to 50 outstanding early career scientists/physicians worldwide.
Read more
In memoriam Anne Moneret-Vautrin
It is with deep sorrow that we received the sad news that Anna Moneret Vautrin passed away last Sunday.
Read more.
The European Medicines Agency launches its new PRIME (PRIority MEdicines) scheme to strengthen support to medicines that target an unmet medical need
PRIME offers early, proactive and enhanced support to medicine developers to optimise the generation of robust data on a medicine’s benefits and risks and enable accelerated assessment of medicine applications.
Read more
Stallergenes Greer: A new web service for Allergy Specialists to stay up to date on Stallergenes Greer product availability
To ensure that allergy specialists stay up to date on Stallergenes Greer product availability in their country, the company has created a dedicated online service. This new service will be regularly updated so that physicians are supported in their daily practice.
Read more.

NIAID Seeks Public Comment on Update to Food Allergy Guidelines
NIAID is seeking public comment on a draft update to the 2010 Guidelines for the Diagnosis and Management of Food Allergy in the US to address the prevention of peanut allergy. The comment period begins March 4 ending April 18.
Read more.
Horizon 2020 Policy Support Facility Launch
EU’s Joint Research Centre Research and Innovation Observatory launches Horizon 2020 Policy Support Facility. Read the complete statement.
The manufacturing and distribution of the products ORALAIR®, ACTAIR® and ALYOSTAL® Venom are starting
EAACI took note of the gradual resumption of manufacturing at the Stallergenes SAS plant in Antony (France) confirmed by the French Health Authority, l’Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM) and published on their website on February 5, 2016.
Read more.
EAACI Immunology Winter School Photos
Check out the photos from Pocol, Cortina d'Ampezzo, Italy
Stallergenes Greer: Resumption of manufacturing at its plant in Antony, France
1 February, 2016
Stallergenes Greer plc announces that the manufacturing and distribution of ORALAIR®, ACTAIR® and ALYOSTAL® Venom starts after a temporary suspension.
Read more.

In Memoriam: Dr. Christoph Grüber (1960-2016)
EAACI mourns the loss of Professor Dr. Christoph Grüber.
Read the In Memoriam by EAACI Executive Member Susanne Lau.
Allergy Think Tank
Munich, 14 January 2016
The ALLERGY THINK TANK was arranged to create space for discussion about science and how to push anti-allergy strategies on a national as well as international level.
Read more.
EU Affairs Monitoring Report - December 2015
Access the December 2015 EU Affairs Monitoring Report
Important message
Companies unrelated to EAACI are using our name pretending to provide official services for the EAACI Congress 2016. Further information can be found here.
EAACI Letter to EU Commission
Read the letter on Allergen products in Europe for diagnosis and treatment.